ライフサイエンスコーパス: endocervical

1 ectomy at our institution for endometrial or endocervical adenocarcinoma over an 11-year interval wer

2 more frequently included the possibility of endocervical adenocarcinoma.

3 HIV-1 infected cells were detected in 51% of endocervical and 14% of vaginal-swab specimens.

4 This study provides evidence that the endocervical and ectocervical epithelia of the human fem

5 Of 25,081 endocervical and male urethral specimens tested by the P

6 , and the impacts of clinical findings (age, endocervical and urethral inflammation, menses, and gono

7 ED Chlamydia Trachomatis Assay (AMP CT) with endocervical and urine specimens were compared to those

8 retinoic acid maintains the simple columnar endocervical and uterine epithelia.

9 71.8 and 9.5% of screening was performed on endocervical and vaginal specimens, respectively, over t

10 evaluated assay performance for women using endocervical and vaginal swabs as well as urine specimen

11 Swabs of labial, vulvar, perineal, perianal, endocervical, and ectocervical tissue were obtained and

12 The endocervical brush appeared to be better than Dacron swa

13 wall scrapings, ectocervical scrapings, and endocervical brushings were analyzed by flow cytometry.

14 guidance, the cervix was cannulated and the endocervical canal was dilated with an angioplasty ballo

15 -1 RNA levels varied least in specimens from endocervical canal wick and most in cervicovaginal lavag

16 Endocervical canal wicks should be considered as an adju

17 s were collected weekly for 8 weeks from the endocervical canal with wicks and cytobrushes and from t

18 nd vagina and the columnar epithelium of the endocervical canal.

19 to the functional internal os along a closed endocervical canal.

20 herein show that, in MCF-7 breast and ECC-1 endocervical cancer cells, the stimulation of aryl hydro

21 cancer that can be clinically confused with endocervical carcinoma.

22 The median number of endocervical CD4 lymphocytes/10,000 cells was greater am

23 they indicate that the presence of a single endocervical cell is as good an indicator of specimen ad

24 the uptake and infection of ectocervical and endocervical cell lines with cell-free fluorescent prote

25 tula is an ineffective device for collecting endocervical cells (for example, odds ratio for comparis

26 35 of 978 specimens) among specimens lacking endocervical cells (P < 0.0001).

27 itivity for C. trachomatis and the number of endocervical cells (P = 0.24).

28 Devices that effectively collect endocervical cells also detect a higher proportion of ab

29 ction of disease and whether the presence of endocervical cells in the smear affects detection of dis

30 The presence of endocervical cells is a valid and convenient surrogate f

31 he two staining methods for detection of the endocervical cells or erythrocytes indicating specimen a

32 Parabasal and endocervical cells showed pattern B spectra.

33 Ectocervical and endocervical cells transfected with miR-negative control

34 A reduction in pmpD null infection of human endocervical cells was associated with a deficiency in c

35 Cervicovaginal secretions and endocervical cells were collected by cytobrush and Inste

36 s compared the ability of devices to collect endocervical cells, and 19 compared the ability of devic

37 of 655 specimens) among specimens containing endocervical cells, whereas it was 3.6% (35 of 978 speci

38 55 (40.1%) were found to contain one or more endocervical cells.

39 atis LCR test is affected by the presence of endocervical cells.

40 of specimen adequacy as the presence of many endocervical cells.

41 ined and examined at x 400 magnification for endocervical (columnar epithelial or metaplastic) cells

42 rs (FSWs) in the Philippines involved weekly endocervical cultures for Neisseria gonorrhoeae, with tr

43 ounders, the levels of all 3 proinflammatory endocervical cytokines were significantly higher in preg

44 was highest among women without mucopurulent endocervical discharge versus those with (relative incre

45 f cervical PCR was highest when mucopurulent endocervical discharge was present (84%) and highest for

46 e to purified rMG309c, vaginal and ecto- and endocervical EC secreted proinflammatory cytokines, incl

47 regulation of chemotactic cytokines by human endocervical, ectocervical, and vaginal epithelial cells

48 l barriers of the vaginal, ectocervical, and endocervical epithelia.

49 compared to the parent strain, within A-431 endocervical epithelial cell cultures.

50 effect of N. gonorrhoeae infection in human endocervical epithelial cells (End/E6E7 cells).

51 OMP proteosomes induce cytokine secretion in endocervical epithelial cells (End/E6E7) but not in uret

52 and the cytokine IL-6 by immortalized human endocervical epithelial cells and the production of IL-8

53 d that a subset of both the ectocervical and endocervical epithelial cells become productively infect

54 ate that N. gonorrhoeae stimulation of human endocervical epithelial cells induces the release of cIA

55 Moreover, epithelial cell lines and primary endocervical epithelial cells released IL-1alpha after C

56 iapoptotic effect of N. gonorrhoeae in human endocervical epithelial cells results from live infectio

57 m can establish long-term infection of human endocervical epithelial cells that results in chronic in

58 Consistent with this, endocervical epithelial cells were unresponsive to prote

59 capable of eliciting chronic inflammation in endocervical epithelial cells.

60 iated gonococci and was more vigorous in the endocervical epithelial cells.

61 ected in otherwise columnar epithelial-lined endocervical glands.

62 Antibody subtype analysis of endocervical IgA was consistent with local mucosal produ

63 inflammatory cytokines, but not with altered endocervical immune cells.

64 response in reproductive tract tissues, the endocervical immune responses of women in Bangladesh wer

65 ithelial cell aggregates to model and assess endocervical infection by M. genitalium.

66 that are distinct from those associated with endocervical infection with Neisseria gonorrhoeae or Chl

67 (91%) mucinous adenocarcinomas, encompassing endocervical, intestinal, and endometrioid histological

68 Endocervical levels of interleukin (IL)-1 beta , IL-6, a

69 factors for cervicitis, which is defined as endocervical mucopurulent discharge or easily induced bl

70 n this SIV-macaque model, that an outside-in endocervical mucosal signalling system, involving MIP-3a

71 In the subset of 344 HSS from whom endocervical or urethral specimens were collected for cu

72 simple hyperplasia (n = 2), polyps (n = 4), endocervical polyp (n = 1), and decidualization (n = 2).

73 mpare, in pregnant versus nonpregnant women, endocervical proinflammatory-cytokine expression in resp

74 oped significant sIgA anti-CtxB responses in endocervical samples (P< or =.02).

75 rmat (HC2-M) with these samples and with 911 endocervical samples collected previously.

76 The results of HC2-RCS for endocervical samples from 330 women were compared to tho

77 Stored endocervical samples from a longitudinal cohort study of

78 Endocervical swabs, female urine, and endocervical samples in liquid-based cytology medium wer

79 specific IgA was detected in the majority of endocervical secretions (94%) and nasal washes (95%) but

80 The median HIV-1 DNA copy number in endocervical secretions from these women (1.8 HIV-1 DNA

81 Endocervical secretions were analyzed for secretory IgA

82 antibody assay (DFA) of sediment from a spun endocervical specimen culture vial and major outer membr

83 e protein-based PCR of the sediment from the endocervical specimen culture vial.

84 olaou stain for microscopic determination of endocervical specimen quality.

85 itive for the detection of C. trachomatis in endocervical specimens and in urine specimens from men a

86 Endocervical specimens collected for any indication for

87 rhoeae were 100 and 99.4%, respectively, for endocervical specimens compared to 90.0 and 95.9% for fe

88 ith a colposcope for genital lesions, tested endocervical specimens for gonorrhea and chlamydia infec

89 The tests were applied to endocervical specimens from 4,980 women attending family

90 67 (12.8%) were PCR positive, and 41 (7.8%) endocervical specimens from the 525 women were culture p

91 the detection of N. gonorrhoeae from female endocervical specimens obtained from patients attending

92 detection of Neisseria gonorrhoeae in 1,490 endocervical specimens obtained from women attending a s

93 The orders of three endocervical specimens of 3,561 women for Chlamydia trac

94 Six hundred one endocervical specimens were analyzed for Chlamydia trach

95 nd specificity of PCR for C. trachomatis for endocervical specimens were both 100% compared to 100 an

96 est system (Digene, Silver Spring, Md.) with endocervical specimens were compared to those of tissue

97 l specimens were PCR positive, and 19 (9.9%) endocervical specimens were culture positive.

98 ndocervical swab PCR positive, and 15 (7.8%) endocervical specimens were culture positive.

99 A total of 403 female endocervical specimens were evaluated.

100 PCR positive for C. trachomatis, 32 (16.7%) endocervical specimens were PCR positive, and 19 (9.9%)

101 he sensitivities of culturing were 84.8% for endocervical specimens, 92.7% for symptomatic male ureth

102 the detection of C. trachomatis infection in endocervical specimens.

103 od for detection of N. gonorrhoeae in female endocervical specimens.

104 dia trachomatis and Neisseria gonorrhoeae in endocervical specimens.

105 n medium for the diagnosis of gonorrhea from endocervical specimens.

106 vical mucus provided some protection for the endocervical surface, by physically trapping virions and

107 ombo 2 assay can be recommended for use with endocervical swab and urine specimens from females, espe

108 simultaneous detection of both pathogens in endocervical swab and urine specimens from females.

109 CT was compared to that of cell culture for endocervical swab and urine specimens from women and ure

110 of culturing was evaluated for 2,192 matched endocervical swab and urine specimens obtained from wome

111 t of culture was evaluated for 2,236 matched endocervical swab and urine specimens obtained from wome

112 positive for N. gonorrhoeae, 23 (12.0%) were endocervical swab PCR positive, and 15 (7.8%) endocervic

113 ne PCR was 93.3%, whereas the sensitivity of endocervical swab specimen culture was 67.3%.

114 R, and all 49 (100%) were positive by either endocervical swab specimen PCR or urine PCR.

115 The resolved sensitivity of the endocervical swab specimen PCR was 86%.

116 cimen, 40 (81.6%) were positive by confirmed endocervical swab specimen PCR, 43 (87.8%) were positive

117 The cellular quality of the endocervical swab specimen used for the detection of Chl

118 %) specimens were positive by culture of the endocervical swab specimen, 40 (81.6%) were positive by

119 for the vaginal swab specimen, 74.3% for the endocervical swab specimen, 61.4% for the urine specimen

120 Plasma samples (obtained weekly) and endocervical swab specimens (obtained thrice weekly) wer

121 imens were tested by culture and AMP CT (717 endocervical swab specimens and 209 urethral swab specim

122 resolved sensitivities of PCR were 92.4% for endocervical swab specimens and 64.8% for female urine s

123 After discrepant analysis, sensitivities for endocervical swab specimens for the EIA and the PACE 2,

124 on by patients, a trained clinician obtained endocervical swab specimens for the same tests.

125 ethral swab and urine specimens from men and endocervical swab specimens from women and thus is well

126 An evaluation of the adequacy of 319 endocervical swab specimens from women attending two inn

127 assay for the detection of C. trachomatis in endocervical swab specimens from women, urethral swab sp

128 ng for C. trachomatis detection in simulated endocervical swab specimens recently distributed interna

129 For the 479 endocervical swab specimens the sensitivity of AMP CT wa

130 The cellular adequacies of 1,633 female endocervical swab specimens were assessed and compared w

131 One urine and four endocervical swab specimens were collected in random ord

132 Of 468 female endocervical swab specimens, 47 (10.0%) had a positive P

133 nsitivities of COBAS AMPLICOR were 89.7% for endocervical swab specimens, 89.2% for female urine spec

134 resolved specificities of PCR were 99.4% for endocervical swab specimens, 99.0% for female urine spec

135 resolved specificities of PCR were 99.5% for endocervical swab specimens, 99.8% for female urine spec

136 Of 415 matched female urine and endocervical swab specimens, there were 49 confirmed inf

137 rachomatis Test has been limited to use with endocervical swab specimens, we conducted an evaluation

138 hose obtained by in vitro culture and PCR of endocervical swab specimens.

139 ) is affected by the cellular quality of the endocervical swab specimens.

140 lected vaginal swab, and clinician-collected endocervical swab) to identify a positive specimen.

141 detect Chlamydia trachomatis rRNA in urine, endocervical swab, and urethral specimens.

142 Vaginal swab, endocervical swab, ThinPrep PreservCyt, and urine specim

143 in Dakar (Senegal) were determined by using endocervical-swab-based PCR DNA amplification assays.

144 f indications for testing among women, using endocervical swabbing samples, 2 M sucrose phosphate tra

145 cted cells were detected in 207 (46%) of 450 endocervical swabs and 74 (16%) of 449 vaginal swabs.

146 total of 408 clinical specimens (324 female endocervical swabs and 84 male urine or urogenital swab

147 Data were available from three endocervical swabs and a urine specimen collected from e

148 from each woman, ranging from 4% to 100% of endocervical swabs and from 0 to 71% of vaginal swabs.

149 tandard, that LCR and PCR tests performed on endocervical swabs and urine are superior to PACE 2 test

150 ae and Chlamydia trachomatis in urethral and endocervical swabs and urine samples from men and women

151 s were detected by use of the combination of endocervical swabs and urine specimens.

152 Endocervical swabs from 1025 female sex workers in Kampa

153 In a comparison of two sampling methods, endocervical swabs were more sensitive than cervicovagin

154 99.0% for vaginal swabs, 100% and 99.4% for endocervical swabs, 100% and 99.6% in ThinPrep samples,

155 or vaginal swabs, 93.4% (88.3% to 96.4%) for endocervical swabs, and 92.9% (87.8% to 96.0%) for femal

156 e urine samples, male urethral swabs, female endocervical swabs, and self-collected and clinician-col

157 nd 96.1% (92.2% to 98.1%) for vaginal swabs, endocervical swabs, female urine samples, and male urine

158 Endocervical swabs, female urine, and endocervical sampl

159 Evaluations included three primer sets, endocervical swabs, vaginal swabs and urine, and various

160 ed with a proprietary cervical brush or with endocervical swabs.

161 l tract-derived cell lines and primary human endocervical tissue can support direct transcytosis of c

162 ble levels across vaginal, ectocervical, and endocervical tissues; however, endocervical Vdelta2 T ce

163 21 women and 2514 men) received a TV NAAT on endocervical, urethral, or urine specimens.

164 ea in females demonstrated sensitivities for endocervical, vaginal, and urine samples of 100.0%, 100.

165 ia in females demonstrated sensitivities for endocervical, vaginal, and urine samples of 97.4%, 98.7%

166 cervical, and endocervical tissues; however, endocervical Vdelta2 T cells showed higher inflammatory